R0158

RepSox

≥98% (HPLC), solid, TGF-β RI kinase inhibitor

• Synonim(y): E-616452; 2-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine
• Wzór empiryczny (zapis Hilla): C₁₇H₁₃N₅
• Numer CAS: 446859-33-2
• Masa cząsteczkowa: 287.32
• UNSPSC Code: 51111800
• PubChem Substance ID: 329823975
• NACRES: NA.77
• MDL number: MFCD09037561
• Assay: ≥98% (HPLC)
• Form: solid

Właściwości

• Nazwa produktu: RepSox, ≥98% (HPLC)
• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: solid
• solubility: DMSO: >20 mg/mL
• storage temp.: 2-8°C
• SMILES string: Cc1cccc(n1)-c2n[nH]cc2-c3ccc4ncccc4n3
• InChI: 1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)
• InChI key: LBPKYPYHDKKRFS-UHFFFAOYSA-N

Opis

Application

RepSox has been used as an inhibitor of autophosphorylation of the transforming growth factor β type I receptor kinase (ALK5).[1] It has also been used as a basal media component for culturing human Pluripotent stem cells.

Biochem/physiol Actions

RepSox Inhibits TGF-beta receptor signaling.

RepSox Inhibits TGF-beta receptor signaling. Retroviral transduction of Sox2, Oct4, and Klf4 genes results in direct reprogramming of somatic cells into induced pluripotent stem cells (iPSCs).

RepSox inhibits osteoclast differentiation, resorption in bone tissues and ovariectomy (OVX)‐induced osteoporosis (OP) through repression of the SMAD family member 3 (Smad3) and c-Jun N-terminal kinase (JNK) pathway/ activator protein 1 (AP-1) pathways.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable